GoldenGolden
Evonetix

Evonetix

Evonetix is a synthetic biology company

Evonetix is a Cambridge, UK-based synthetic biology company. The main goals of the company are to engineer metabolic pathways and organisms, improve industrial processes, and create new processes. Evonetix also engineers genomes with new and improved traits and use DNA as a medium for digital data storage.

Timeline

March 2, 2020
Evonetix raises a $30,000,000 series B round from Foresite Capital.
July 2, 2018
Evonetix raises a $1,805,375 grant from Innovate UK.
January 30, 2018
Evonetix raises a $12,300,000 series A round from Cambridge Consultants, Civilization Ventures, DCVC Bio, Draper Esprit, Providence Investment Company Limited and Rising Tide.
2015
Evonetix was founded by Joseph Brennan and Matthew Hayes.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.